ClinicalTrialsFinder

Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) Clinical Trials in Boston, Massachusetts

1 recruitingBoston, Massachusetts

Showing 1–1 of 1 trials

Recruiting
Phase 1

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Metastatic Breast CancerAdvanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)+3 more
Olema Pharmaceuticals, Inc.180 enrolled8 locationsNCT06784193